Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly Send to Friend Enquire before Buying Electronic (PDF)   Site License   Enterprisewide   Competitor Analysis: PTH Receptor Agonists La Merie, Jan 2009, Pages: 18   Description     Table of Contents        Enquire before Buying    Send to a Friend   The present Competitive Intelligence Report about Parathyroid Hormone (PTH) Receptor Agonists or PTH Analogs provides a competitor evaluation in the field of R&D projects with analogs of PTH used to stimulate the PTH receptor for the treatment of osteoporosis or other bone-related diseases as of January 2009. PTH analogs are recombinant and synthetic peptides delivered by injection, inhalation, nasal, oral and transdermal administration. The report includes a compilation of current active projects in research and development of PTH receptor agonists. In addition, the report lists company-specific pipelines of PTH receptor agonists. Competitor projects are listed in a tabular format providing information on: - Drug Codes - Target / Mechanism of Action - Class of Compound - Company - Product Category - Indication - R&D Stage and additional comments with a hyperlink leading to the source of information.

		Top of page

All rights reserved. ? Copyright 2009 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster